This is a working overview of reference standard, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-11-27 and is reviewed periodically as new material appears.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
| Property | Value | Notes |
|---|---|---|
| Solid-state storage | -20 degrees Celsius or lower | Desiccated and protected from light |
| Solution stability | Short and method-dependent | Confirm by stability testing |
| Purity assessment | Reversed-phase HPLC | Reported as area percent |
| Identity confirmation | LC-MS or comparable method | Mass match against expected value |
| Common synonyms | MT-II; melanotan II | Informal and catalogue names |
Verification of a purchased sample requires documentation linking a batch to a certificate of analysis, and that document should be read for the methods used rather than the headline purity figure. A single chromatographic percentage does not establish identity. Independent laboratories can perform identity and content assays, but no such test establishes that a product is suitable for human use. Claims about efficacy rest largely on small, early studies rather than on replicated controlled trials, and that gap remains open.
Identity testing for a cyclic peptide of this size usually relies on reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The mass spectrum confirms molecular weight, while the chromatographic trace indicates the proportion of related impurities. Tandem mass spectrometry can provide sequence-level information when fragmentation data are compared against a reference standard. Nuclear magnetic resonance is sometimes used to confirm the lactam bridge, although it requires more material and greater operator expertise than routine chromatographic methods.
Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.
Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.
Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.
Identification in laboratories relies on reversed-phase liquid chromatography coupled with tandem mass spectrometry, with product-ion spectra compared against a certified reference standard. High-resolution mass spectrometry supplies accurate mass confirmation, and peptide mapping after enzymatic digestion separates melanotan II from closely related analogues. Quantitation of seized material is complicated by unknown counter-ions and residual trifluoroacetate left from purification. Immunoassays raised against alpha-melanocyte-stimulating hormone can cross-react, so chromatographic confirmation is normally required. Urinary detection windows are short, and reported limits of detection differ substantially between laboratories.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
Residues from processing of uranium ore can also be a source of radon. Radon resulting from the high radium content in uncovered dumps and tailing ponds can be easily released into the atmosphere and affect people living in the vicinity. The release of radon may be mitigated by covering tailings with soil or clay, though other decay products may leach into groundwater supplies. Non-uranium mines may pose higher risks of radon exposure, as workers are not continuously monitored for radiation, and regulations specific to uranium mines do not apply. A review of radon level measurements across non-uranium mines found the highest concentrations of radon in non-metal mines, such as phosphorus and salt mines. However, older or abandoned uranium mines without ventilation may still have extremely high radon levels. In addition to lung cancer, researchers have theorized a possible increased risk of leukemia due to radon exposure. Empirical support from studies of the general population is inconsistent; a study of uranium miners found a correlation between radon exposure and chronic lymphocytic leukemia, and current research supports a link between indoor radon exposure and poor health outcomes (i.e., an increased risk of lung cancer or childhood leukemia).
Furin is a protease, a proteolytic enzyme activated by substrate presentation that in humans and other animals is encoded by the FURIN gene. Some proteins are inactive when they are first synthesized, and must have sections removed in order to become active. Furin cleaves these sections and activates the proteins. It was named furin because it was in the upstream region of an oncogene known as FES. The gene was known as FUR (FES Upstream Region) and therefore the protein was named furin. Furin is also known as PACE (Paired basic Amino acid Cleaving Enzyme). A member of family S8, furin is a subtilisin-like peptidase.
=== Without feline features === In ancient Assyria, bas-reliefs of shedu bulls with the crowned bearded heads of kings guarded the entrances of temples. Many Greek mythological creatures who are archaic survivals of previous mythologies with respect to the classical Olympian mythology, like the centaurs, are similar to the Sphinx.
Oil-eating bacteria biodegrade oil that has escaped to the surface. Oil sands are reservoirs of partially biodegraded oil still in the process of escaping and being biodegraded, but they contain so much migrating oil that, although most of it has escaped, vast amounts are still present—more than can be found in conventional oil reservoirs. The lighter fractions of the crude oil are destroyed first, resulting in reservoirs containing an extremely heavy form of crude oil, called crude bitumen in Canada, or extra-heavy crude oil in Venezuela. These two countries have the world's largest deposits of oil sands. On the other hand, oil shales are source rocks that have not been exposed to heat or pressure long enough to convert their trapped hydrocarbons into crude oil. Technically speaking, oil shales are not always shales and do not contain oil, but are fined-grain sedimentary rocks containing an insoluble organic solid called kerogen. The kerogen in the rock can be converted into crude oil using heat and pressure to simulate natural processes. The method has been known for centuries and was patented in 1694 under British Crown Patent No. 330 covering, "A way to extract and make great quantities of pitch, tar, and oil out of a sort of stone." Although oil shales are found in many countries, the United States has the world's largest deposits.
=== Austria === In the 2013 legislative election the Social Democratic Party of Austria and the Austrian People's Party lost 5 seats and 4 seats, respectively, but with a total of 99 seats they remained in majority. On 14 October 2013 the two parties began government formation talks with each other, which resulted in the grand coalition of the Second Faymann government that was appointed by President of Austria Heinz Fischer. On 17 May 2016, it was succeeded by the Kern government, following Faymann's resignation amidst the 2016 presidential election. The First Kurz government was formed after the 2017 legislative election. Sebastian Kurz, chairman of the centre-right Austrian People's Party, known by its initials in German as ÖVP, reached an agreement on a coalition with the far-right Freedom Party of Austria (FPÖ), setting the stage for Kurz to become chancellor of Austria—the youngest head of government in Europe—for the first time. The Ibiza affair was a political scandal in Austria involving Heinz-Christian Strache, the former vice chancellor of Austria and leader of the Freedom Party (FPÖ), and Johann Gudenus, a deputy leader of the Freedom Party. The scandal caused the collapse of the Austrian governing coalition on 18 May 2019 and the announcement of an early election.
Sources: en.wikipedia.org
Lowrie has played Sherlock Holmes in the radio drama series The Further Adventures of Sherlock Holmes on the program Imagination Theatre since 2001. He also voiced Holmes in the program's related radio series The Classic Adventures of Sherlock Holmes. He and Lawrence Albert, who voices Dr. Watson on the program, are the longest-running audio Holmes and Watson team in American radio history. In 2011, he published a science fiction novel titled Dancing with Eternity. An audiobook version narrated by Lowrie and McLain was released in April 2014. In 2021, Lowrie directed a livestreamed version of the play 'night, Mother starring his wife Ellen McLain and Sheila Houlahan on the online platform Twitch with the story adapted by McLain within the context of the COVID-19 pandemic. The filmed online play is performed through an online face-to-face chat with the screen split between McLain's and Houlahan's screens, occasionally interrupted by cuts to pre-filmed footage relevant to the story. Lowrie has also had small roles in several live-action films, most notable of which being the 2025 critically acclaimed period drama Train Dreams as a foreman overlooking the construction of a railroad for the Spokane International Railway (credited as Mr. Sears).
=== Conclusion === Intracrines are fundamental to development, acting as intracellular regulators that guide stem cell differentiation, organogenesis, and tissue remodeling. By establishing self-sustaining feedback loops, intracrines ensure that developmental programs continue even after the initial external signals disappear. Understanding these mechanisms not only provides insights into embryonic development but also offers promising strategies for regenerative medicine and tissue engineering. As research into intracrine biology advances, it holds the potential to revolutionize therapeutic approaches for organ repair, disease treatment, and stem cell-based therapies.
The theme was expanded to form great avenues of guardian sphinxes lining the approaches to tombs and temples as well as serving as details atop the posts of flights of stairs to very grand complexes. Nine hundred sphinxes with ram heads (Criosphinxes), believed to represent Amon, were built in Thebes, where his cult was strongest. At Karnak, each Criosphinx is fronted by a full-length statue of the pharaoh. The task of these sphinxes was to hold back the forces of evil. The Great Sphinx has become an emblem of Egypt, frequently appearing on its stamps, coins, and official documents. In March 2023, a limestone sphinx was discovered at the Dendera Temple Complex. This sphinx, which is depicted with a slight grin and dimples, is thought to be made in the image of the Roman emperor Claudius.
== Signs and symptoms == Pain may be the first noticed symptom. People with lipodermatosclerosis have tapering of their legs above the ankles, forming a constricting band resembling an inverted champagne bottle. In addition, there may be brownish-red pigmentation and induration. Symptoms may also include swelling in feet and ankles, leathery skin, flaky skin, itchy skin, leg cramping, leg heaviness, leg swelling, leg tiredness, leg achiness, foot pain, slow healing wounds on legs and feet, bulging varicose veins, warmth in legs, redness in legs, and pain with prolonged standing.
As these fluids flow past each other, they create a heat gradient in which heat is transferred and retained inside the body. The warm arterial blood transfers most of its heat to the cool venous blood now coming in from the outside. This conserves heat by recirculating it back to the body core. Since the arteries give up a good deal of their heat in this exchange, there is less heat lost through convection at the periphery surface. Another example is found in the legs of an Arctic fox treading on snow. The paws are necessarily cold, but blood can circulate to bring nutrients to the paws without losing much heat from the body. Proximity of arteries and veins in the leg results in heat exchange, so that as the blood flows down it becomes cooler, and does not lose much heat to the snow. As the (cold) blood flows back up from the paws through the veins, it picks up heat from the blood flowing in the opposite direction, so that it returns to the torso in a warm state, allowing the fox to maintain a comfortable temperature, without losing it to the snow. This system is so efficient that the Arctic fox does not begin to shiver until the temperature drops to −70 °C (−94 °F).
Sources: en.wikipedia.org
Laboratory confirmation typically combines retention time matching on a chromatographic system with mass measurement. A reference standard of known identity is needed for a meaningful comparison. Sequence-level techniques can add further confirmation.
There is no single harmonised standard governing these products, and manufacturing conditions differ. Impurities may include truncated sequences, oxidation products, residual solvents, and counter-ions. Independent testing is often the only way to characterise a given lot.
Reported studies have looked at pigmentation, photoprotection, and metabolic or appetite-related endpoints in small experimental settings. Much of the evidence base is early-stage and limited in size. Questions about long-term effects and clinical relevance remain open.
No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.